The largest database of trusted experimental protocols

Brdu b5002

Manufactured by Merck Group
Sourced in United States

BrdU (B5002) is a nucleoside analog of thymidine that can be incorporated into the DNA of dividing cells as a substitute for thymidine. It is commonly used as a cell proliferation marker in biological research.

Automatically generated - may contain errors

16 protocols using brdu b5002

1

Detecting Pregranulosa Cell Proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
For detection of pregranulosa cell proliferation, bromodeoxyuridine (BrdU, B5002; Sigma) was added to the medium to 10 μM and incubated for 1 h at 37°C. The ovaries were fixed in 4% paraformaldehyde overnight at 4°C for immunofluorescence analysis.
+ Open protocol
+ Expand
2

Immunohistochemical Profiling of Cellular Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following antibodies were used for immunohistochemical analyses: 5-bromo-2-deoxyuridine (BrdU, MAS-250) from Accurate Scientific (Westbury, NY); estrogen receptor α (ERα; SC-542) from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA); β-catenin (610153) from BD Biosciences (San Jose, CA); Notch1 (Ab52627) from Abcam (Cambridge, MA). iCRT14 (SML-0203), γ-Secretase Inhibitor (S2188; CAS Number 200810-93-1) and BrdU (B5002) were obtained from Sigma-Aldrich (St. Louis, MO).
+ Open protocol
+ Expand
3

Bromodeoxyuridine (BrdU) Injection Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bromodeoxyuridine (BrdU-B5002, Sigma-Aldrich) was intraperitoneally (i.p.) injected (50 mg/Kg of animal weight) immediately after the preparation of a solution of 50 mg/mL, 10% in dimethyl sulfoxide (DMSO) [8] (link). Injections were performed twice daily, beginning at the day of CFA or CFA vehicle intra-articular injection (day 0), until 24 h prior to animals sacrifice (to allow BrdU clearance) by intracardiac perfusion, as described below. The following experimental groups were used: controls (CFA-vehicle non-inflamed rats injected with BrdU until day 3 and sacrificed at day 4; N = 6 rats), 4d MA (CFA-inflamed rats injected with BrdU until day 3 and sacrificed with 4d of disease; N = 5 rats) and 7d of MA (CFA-inflamed rats injected with BrdU until day 6 and sacrificed with 7d of disease; N = 6 rats). Prior to these experiments, a group of naive animals was injected twice a day, with 10% DMSO solution i.p., for 6 days and no toxic effects or signs of peritoneal inflammation were found (data not shown).
+ Open protocol
+ Expand
4

Primordial Folliculogenesis Regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ovaries were separated from mouse ovarian capsules in prechilled PBS (10 mM, pH 7.4). The isolated ovaries were cultured in 6-well culture dishes (NEST Biotechnology) with 1.1 ml of basic DMEM/F12 (Gibco, Life Technologies) at 37°C in a 5% CO2/95% air atmosphere with saturated humidity. Half of the medium was replaced every two days until the ovaries grew to the required stage. To determine the role of SP1 in primordial folliculogenesis, ovaries were treated with lentivirus containing shRNA (at 15.5 dpc) or with the SP1 inhibitor MIT (100 nM; M6891; Sigma-Aldrich) (at 16.5 dpc). For the BrdU incorporation assay, ovaries were treated with BrdU (B5002; Sigma-Aldrich) for 1 h before being collected for analysis.
+ Open protocol
+ Expand
5

BrdU Labeling of Proliferating Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
We conducted this experiment using a method described recently [43 (link), 44 (link)]. Briefly, BrdU (B5002, Sigma-Aldrich) was intraperitoneally injected to dams at E17.5 or pups at P0 with the concentration of 100 mg/kg. Brains were collected 30 min after the injection for E17.5 or 2 h after the injection for P0.
+ Open protocol
+ Expand
6

Cell Cycle Analysis by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
For cell cycle analysis, two-color flow-cytometric analysis was used for accurate determination of the cell cycle profile. Mock-infected and infected cells were pulsed with bromodeoxyuridine (BrdU [B5002; Sigma, Saint Louis, MO, USA] 10 μM to approximately 1 × 106 cells) for 1 h prior to harvesting with trypsin. Cells were fixed with ice-cold 70% ethanol at 4 ℃ overnight and then treated with 2 N HCl containing 0.5% Triton X-100 for 30 min. Residual acid was neutralized by incubating the cell suspension with 0.1 M sodium borate (pH 8.5) for 2 min at room temperature. Cells were then incubated with anti-BrdU-FITC solution (anti-BrdU-FITC antibody [556028; BD Biosciences Pharmingen, San Diego, CA, USA] in a 1:5 dilution) at 4 ℃ overnight. The cell suspension was incubated with propidium iodide (PI) staining solution in phosphate buffered saline (PBS) (50 μg/ml PI [Sigma, Saint Louis, MO, USA] and 200 μg/ml RNase [Beyotime, Shanghai, China]) for 30 min at 37 ℃ and then analyzed with a FACSCalibur Flow Cytometer (Beckman, Mississauga, ON, Canada) and FlowJo software.
+ Open protocol
+ Expand
7

BrdU Proliferation Assay in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
For proliferation studies, mice received a single i.p. injection of 60μg/g body weight of BrdU (B5002, Sigma-Aldrich) 2 h prior to sample collection.
+ Open protocol
+ Expand
8

Tbr2-CreER(T2) Mice Embryo Labeling

Check if the same lab product or an alternative is used in the 5 most similar protocols
For Tbr2‐CreERT2 mice, pregnant dams were intraperitoneally administered tamoxifen (TM; T5648, Sigma‐Aldrich; 10 mg/kg) and progesterone (P3972, Sigma‐Aldrich; 5 mg/kg) dissolved in corn oil. Embryos were acquired at E18.5 through caesarean section, and they were fostered by other synchronous lactating females. Brains were collected at P7 for further analysis. Fresh bromodeoxyuridine (BrdU, B5002, Sigma‐Aldrich) or idoxuridine (IdU, 1336001, USP) solution (concentration 50 mg/kg) was injected intraperitoneally into pregnant females at the indicated embryonic ages.
+ Open protocol
+ Expand
9

Nanoparticle-Mediated Gene Silencing in Zebrafish

Check if the same lab product or an alternative is used in the 5 most similar protocols
siRNAs were encapsulated in polyethylene glycol–polylactic acid nanoparticles using a double emulsion-solvent evaporation technique and then injected into the pericardial sac40 (link)65 66 (link). Briefly, zebrafish were allowed to recover for 1 day after ventricular resection. To evaluate the effect of siRNA on its target gene expression, the hearts were collected at 2 d.p.a., and total RNA was isolated to assess the expression of the respective genes by quantitative RT–PCR. To evaluate the effect of genes on cardiomyocyte proliferation, 50 μl polyethylene glycol–polylactic acid nanoparticle-encapsulated siRNAs was injected first, and ∼1 h later, 50 μl 2.5 mg ml−1 BrdU (B5002; Sigma) was injected into the thoracic cavity daily from 7 to 14 d.p.a. The hearts at 14 d.p.a. were collected for subsequent experiments. siRNA sequences for cdkn1a, cdkn1c and dnmt3ab are shown in Supplementary Table 2.
+ Open protocol
+ Expand
10

Isolation and Culture of Neonatal Rat Cardiomyocytes and Fibroblasts

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cardiomyocytes (CMs) and cardiac fibroblasts (CFs) were harvested from 1‐ to 3‐day‐old neonatal rats. Briefly, rat's heart was quickly removed and 0.04% collagenase II was employed to digest the minced ventricles for six cycles. Cells were harvested and suspended in DMEM medium enriched with 10% FBS. CMs and CFs were collected by differential centrifugation. After 48 hours of culture, BrdU (b5002, sigma Aldrich, United States) was added to the CMs to remove a small amount of residual CFs. CFs were cultured continuously and passaged normally. The second generation was used for experiment.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!